BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37552260)

  • 1. Assessment of early anthracycline-induced cardiotoxicity and liver injury with T2 and T2* mapping in rabbit models.
    Feng XL; Qi WY; Xiao ZY; Zheng X; Zhang XY; Liu T; Kou XY; Chen J
    Eur Radiol; 2024 Jan; 34(1):226-235. PubMed ID: 37552260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity.
    Galán-Arriola C; Lobo M; Vílchez-Tschischke JP; López GJ; de Molina-Iracheta A; Pérez-Martínez C; Agüero J; Fernández-Jiménez R; Martín-García A; Oliver E; Villena-Gutierrez R; Pizarro G; Sánchez PL; Fuster V; Sánchez-González J; Ibanez B
    J Am Coll Cardiol; 2019 Feb; 73(7):779-791. PubMed ID: 30784671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrahigh-field cardiovascular magnetic resonance T1 and T2 mapping for the assessment of anthracycline-induced cardiotoxicity in rat models: validation against histopathologic changes.
    Park HS; Hong YJ; Han K; Kim PK; An E; Lee JY; Park CH; Lee HJ; Hur J; Kim YJ; Choi BW
    J Cardiovasc Magn Reson; 2021 Jun; 23(1):76. PubMed ID: 34134713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-parameter cardiac magnetic resonance imaging detects anthracycline-induced cardiotoxicity in rabbits model.
    Hu Y; Ma P; Chen L; Liu J; Shang Y; Jian W
    Heliyon; 2023 Nov; 9(11):e21845. PubMed ID: 38058655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Detection and Serial Monitoring of Anthracycline-Induced Cardiotoxicity Using T1-mapping Cardiac Magnetic Resonance Imaging: An Animal Study.
    Hong YJ; Park HS; Park JK; Han K; Park CH; Kim TK; Yoo SJ; Lee JY; Kim PK; Hur J; Lee HJ; Kim YJ; Suh YJ; Paek MY; Choi BW
    Sci Rep; 2017 Jun; 7(1):2663. PubMed ID: 28572614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial Cardiac MRI for Quantification of the Dynamics of Anthracycline-Induced Subclinical Myocardial Injury.
    Zheng Y; Liu H; Zhao L; Guan S; Huo H; Li H; Guo J; Peng X; Hao Y; Jin S; Hou Y; Dai X; Liu T; Zhang X
    J Magn Reson Imaging; 2023 Nov; 58(5):1533-1541. PubMed ID: 36912379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Native Myocardial T1 Mapping for Early Detection of Anthracycline-Induced Cardiotoxicity in Patients with Cancer: a Systematic Review and Meta-analysis.
    Mohamed AA; Elmancy LY; Abulola SM; Al-Qattan SA; Mohamed Ibrahim MI; Maayah ZH
    Cardiovasc Toxicol; 2024 Jun; 24(6):563-575. PubMed ID: 38700665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of Global Longitudinal Strain and NT-proBNP on Early Development of Cardiotoxicity in Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy.
    Muckiene G; Vaitiekus D; Zaliaduonyte D; Zabiela V; Verseckaite-Costa R; Vaiciuliene D; Juozaityte E; Jurkevicius R
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241185
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of early anthracycline-induced cardiotoxicity using segmental strain of cardiac magnetic resonance compared with global strain and functional parameters: an animal study.
    Liu JQ; Luo QF; Qi WY; Xiao ZY; Zhang XY; Lan YS; Chen J
    Quant Imaging Med Surg; 2023 Sep; 13(9):5511-5524. PubMed ID: 37711795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying early stages of doxorubicin-induced cardiotoxicity in rat model by 7.0 tesla cardiovascular magnetic resonance combining hematological and pathological parameters.
    Wang S; Zhu T; Wang C; Wang L; He B; Gao F
    Magn Reson Imaging; 2022 Jul; 90():17-25. PubMed ID: 35122985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using T1-weighted and T2-weighted cardiovascular magnetic resonance.
    Jordan JH; D'Agostino RB; Hamilton CA; Vasu S; Hall ME; Kitzman DW; Thohan V; Lawrence JA; Ellis LR; Lash TL; Hundley WG
    Circ Cardiovasc Imaging; 2014 Nov; 7(6):872-9. PubMed ID: 25273568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients from Southern Sri Lanka: An Echocardiographic Analysis.
    Sandamali JAN; Hewawasam RP; Fernando MACSS; Jayatilaka KAPW; Madurawe RD; Sathananthan PP; Ekanayake U; Horadugoda J
    Biomed Res Int; 2020; 2020():1847159. PubMed ID: 33274195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 4 (TLR4) expression is correlated with T2* iron deposition in response to doxorubicin treatment: cardiotoxicity risk assessment.
    Trofenciuc NM; Bordejevic AD; Tomescu MC; Petrescu L; Crisan S; Geavlete O; Mischie A; Onel AFM; Sasu A; Pop-Moldovan AL
    Sci Rep; 2020 Oct; 10(1):17013. PubMed ID: 33046755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity.
    Meiners B; Shenoy C; Zordoky BN
    Biol Sex Differ; 2018 Aug; 9(1):38. PubMed ID: 30157941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac MRI Myocardial Functional and Tissue Characterization Detects Early Cardiac Dysfunction in a Mouse Model of Chemotherapy-Induced Cardiotoxicity.
    Naresh NK; Misener S; Zhang Z; Yang C; Ruh A; Bertolino N; Epstein FH; Collins JD; Markl M; Procissi D; Carr JC; Allen BA
    NMR Biomed; 2020 Sep; 33(9):e4327. PubMed ID: 32567177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of subclinical diastolic dysfunction by cardiac magnetic resonance feature-tracking in adult survivors of non-Hodgkin lymphoma treated with anthracyclines.
    Barbosa MF; Fusco DR; Gaiolla RD; Werys K; Tanni SE; Fernandes RA; Ribeiro SM; Szarf G
    BMC Cardiovasc Disord; 2021 Apr; 21(1):170. PubMed ID: 33845778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep learning-assisted high-content screening identifies isoliquiritigenin as an inhibitor of DNA double-strand breaks for preventing doxorubicin-induced cardiotoxicity.
    Chen X; Liu C; Zhao H; Zhong Y; Xu Y; Wang Y
    Biol Direct; 2023 Oct; 18(1):63. PubMed ID: 37807075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late cardiac effect of anthracycline therapy in physically active breast cancer survivors - a prospective study.
    Nagy AC; GulAcsi-BArdos P; CserEp Z; Hangody L; Forster T
    Neoplasma; 2017; 64(1):92-100. PubMed ID: 27881009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early detection of the cardiotoxicity induced by chemotherapy drug through two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T].
    Wang W; Kang Y; Shu XH; Shen XD; He B
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):835-840. PubMed ID: 29151290
    [No Abstract]   [Full Text] [Related]  

  • 20. Myocardial Characterization Using Dual-Energy CT in Doxorubicin-Induced DCM: Comparison With CMR T1-Mapping and Histology in a Rabbit Model.
    Hong YJ; Kim TK; Hong D; Park CH; Yoo SJ; Wickum ME; Hur J; Lee HJ; Kim YJ; Suh YJ; Greiser A; Paek MY; Choi BW
    JACC Cardiovasc Imaging; 2016 Jul; 9(7):836-845. PubMed ID: 27236517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.